ADAR1 Capital Management »

J P Morgan Exchange Traded F ultra shrt shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of J P Morgan Exchange Traded F ultra shrt (JPST) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in J P Morgan Exchange Traded F ultra shrt

Tip: Access up to 7 years of quarterly data

All positions including J P Morgan Exchange Traded F ultra shrt held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in J P Morgan Exchange Traded F ultra shrt by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.5M 49k 50.23

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding J P Morgan Exchange Traded F ultra shrt

Jpmorgan Chase & Co
Bank of America Corporation
Charles Schwab Investment Management
UBS Group
HB Wealth Management
Wells Fargo & Company
Jane Street
Wealth Enhancement Advisory Services
Betterment
HPM Partners
Royal Bank of Canada
Advisor Group Holdings
Townsquare Capital
Raymond James Financial Services Advisors
AE Wealth Management

View all funds holding J P Morgan Exchange Traded F ultra shrt